Study Results Show Long-term Efficacy of iTind Procedure

/PRNewswire/ -- Olympus, a leading global medtech company providing innovative solutions for medical and surgical procedures, announced today the summary...

Related Keywords

Germany ,Italy ,Hamburg ,United States ,American ,Vanessa Malka ,Francesco Porpiglia ,Urol Nephrol ,Urology Care Foundation ,University Of Turin ,Urology Division At San Luigi Gonzaga Hospital ,American Urological Association Annual Meeting ,Tind Commercial Head For Olympus Corporation ,Olympus Corporation ,International Prostate Symptom Score ,Durability Study Results ,Tind Procedure Presented ,Urological Association Annual Meeting ,Professor Francesco Porpiglia ,Urology Division ,San Luigi Gonzaga Hospital ,Executive Director ,Tind Commercial Head ,International Multicenter Prospective Study ,Temporary Implantable Nitinol Device ,Lower Urinary Tract Symptoms ,Benign Prostatic Hyperplasia ,Updated September ,Eurology Care ,Accessed November ,Int Urol ,Temporarily Implanted Nitinol Device ,Lower Urinary Tract Symptoms Secondary ,Controlled Trial ,